Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 27.86 USD 0.25% Market Closed
Market Cap: 861.2m USD

Fulgent Genetics Inc
Common Shares Outstanding

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Fulgent Genetics Inc
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Fulgent Genetics Inc
NASDAQ:FLGT
Common Shares Outstanding
$30.9m
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Common Shares Outstanding
$111m
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
CVS Health Corp
NYSE:CVS
Common Shares Outstanding
$1.3B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Cigna Corp
NYSE:CI
Common Shares Outstanding
$266.6m
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Laboratory Corporation of America Holdings
NYSE:LH
Common Shares Outstanding
$83m
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Guardant Health Inc
NASDAQ:GH
Common Shares Outstanding
$125m
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Fulgent Genetics Inc
Glance View

Market Cap
859.6m USD
Industry
Health Care

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.

FLGT Intrinsic Value
18.12 USD
Overvaluation 35%
Intrinsic Value
Price

See Also

What is Fulgent Genetics Inc's Common Shares Outstanding?
Common Shares Outstanding
30.9m USD

Based on the financial report for Sep 30, 2025, Fulgent Genetics Inc's Common Shares Outstanding amounts to 30.9m USD.

What is Fulgent Genetics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
6%

Over the last year, the Common Shares Outstanding growth was 1%. The average annual Common Shares Outstanding growth rates for Fulgent Genetics Inc have been 1% over the past three years , 6% over the past five years .

Back to Top